Heritability of genetic variants of resistin gene in patients with coronary artery disease: A family-based study

Clinical Biochemistry

Volumn 44, Issue 8-9, 2011, Pages 618-622

  Hussain, Sabir ^a   Bibi, Shakeela ^a   Javed, Qamar ^a  

^a QUAID I AZAM UNIVERSITY   (Pakistan)

Author keywords

Atherosclerosis; Coronary disease; Heredity; Polymorphism; Resistin

Indexed keywords

RESISTIN;

ADULT; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL DISEASE; FAMILY STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HERITABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PAKISTAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; CORONARY ARTERY DISEASE; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RESISTIN;

EID: 79955869851     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.02.013     Document Type: Article

References (36)

1. Scheuner M.T., Wang S.J., Raffel L.J., et al. Family history: a comprehensive genetic risk assessment method for the chronic conditions of adulthood. Am J Med Genet 1997, 71:315-324.
2. Youhanna S., Platt D.E., Rebeiz A., et al. Parental consanguinity and family history of coronary artery disease strongly predict early stenosis. Athersclerosis 2010, 212:559-563.
3. Fischer M., Mayer B., Baessler A., et al. Familial aggregation of left main coronary artery disease and future risk of coronary events in asymptomatic siblings of affected patients. Eur Heart J 2007, 28:2432-2437.
4. The PROCARDIS Consortium A trio family study showing association of lymphotoxin-ά N26 (804A) allele with coronary artery disease. Eur J Hum Genet 2004, 12:770-774.
5. Allen A., Belton C., Patterson C., et al. Family-based association studies of lipid gene polymorphisms in coronary artery disease. Am J Cardiol 2005, 96:52-55.
6. Spielman R.S., McGinnis R.E., Ewens W.J. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993, 52:506-516.
7. Steppan C.M., Bailey S.T., Bhat S., et al. The hormone resistin links obesity to diabetes. Nature 2001, 409:307-312.
8. Patel L., Buckels A.C., Kinghorn I.J., et al. Resistin is expressed in human macrophages and directly by PPAR gamma activators. Biochem Biophys Commun 2003, 300:472-476.
9. Reilly M.P., Lehrke M., Wolfe M.L., Rohatgi A., Lazar M.A., Rader D.J. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005, 111:932-939.
10. Tang N.P., Wang L.S., Yang L., et al. A polymorphism in the resistin gene promoter and the risk of coronary artery disease in a Chinese population. Clin Endocrinol 2008, 68:82-87.
11. Burnett M.S., Lee C.W., Kinnaird T.D., et al. The potential role of resistin in atherogenesis. Atherosclerosis 2005, 182:241-248.
12. Kawanami D. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Commun 2004, 314:415-419.
13. Verma S., Li S.H., Wang C.H., et al. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 2003, 108:736-740.
14. Azuma K., Oguchi S., Matsubara Y., et al. Novel resistin promoter polymorphisms: association with serum resistin level in Japanese obese individuals. Horm Metab Res 2004, 36:564-570.
15. Osawa H., Yamada K., Onuma H., et al. The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am J Hum Genet 2004, 75:678-686.
16. Ohmori R., Momiyama Y., Kato R., et al. Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. J Am Coll Cardiol 2005, 46:379-380.
17. Pischon T., Bamberger C.M., Kratzsch J., et al. Association of plasma resistin levels with coronary heart disease in women. Obes Res 2005, 13:1764-1771.
18. Yaturu S., Daberry R.P., Rains J., Jain S. Resistin and adiponectin levels in subjects with coronary artery disease and type 2 diabetes. Cytokine 2006, 34:219-223.
19. Lim S., Koo B.K., Cho S.W., et al. Association of adiponectin and resistin with cardiovascular events in Korean patients with type 2 diabetes: the Korean atherosclerosis study (KAS): a 42-month prospective study. Atherosclerosis 2008, 196:398-404.
20. Ledru F., Ducimetière P., Battaglia S., et al. New diagnostic criteria for diabetes and coronary artery disease: insights from an angiographic study. J Am Coll Cardiol 2001, 37:1543-1550.
21. Hussain S., Asghar M., Javed Q. Resistin gene promoter region polymorphism and the risk of hypertrophic cardiomyopathy in patients. Transl Res 2010, 155:142-147.
22. Kunnari A., Ukkola O., Kesaniemi Y.A. Resistin polymorphisms are associated with cerebrovascular disease in Finnish type 2 diabetic patients. Diabet Med 2005, 22:583-589.
23. Ochi M., Osawa H., Hirota Y., et al. Frequency of the G/G genotype of resistin single nucleotide polymorphism at -420 appears to be increased in younger-onset type 2 diabetes. Diabetes 2007, 56:2834-2838.
24. Ochi M., Osawa H., Onuma H., et al. The absence of evidence for major effects of the frequent SNP +299G>A in the resistin gene on susceptibility to insulin resistance syndrome associated with Japanese type 2 diabetes. Diab Res Clin Pract 2003, 61:191-198.
25. Ukkola O., Kunnari A., Kesaniemi Y.A. Genetic variants at the resistin locus are associated with the plasma resistin concentration and cardiovascular risk factors. Regul Pept 2008, 149:56-59.
26. Krizova J., Dolinkova M., Lacinova Z., et al. Adiponectin and resistin gene polymorphisms in patients with anorexia nervosa and obesity and its influence on metabolic phenotype. Physiol Res 2008, 57:539-546.
27. Duan S., Gaoa R., Zinga Q., et al. A family-based association study of schizophrenia with polymorphisms at three candidate genes. Neurosci Lett 2005, 379:32-36.
28. Stopkova P., Saito T., Papolos D.F., et al. Identification of PIK3C3 promoter variant associated with bipolar disorder and schizophrenia. Biol Psychiatry 2004, 55:981-988.
29. Bokarewa M., Nagaev I., Dahlberg L., Smith U., Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005, 174:5789-5795.
30. Tsukahara T., Nakashima E., Watarai A., et al. Polymorphism in resistin promoter region at -420 determines the serum resistin levels and may be a risk marker of stroke in Japanese type 2 diabetic patients. Diabetes Res Clin Pract 2009, 84:179-186.
31. Tang N.P., Wang L.S., Yang L., et al. A polymorphism in the resistin gene promoter is related to increased C-reactive protein levels in patients with coronary artery disease. Clin Chem Lab Med 2007, 45:1471-1477.
32. Miyamotoa Y., Morisakib H., Kokuboc Y., et al. Resistin gene variations are associated with the metabolic syndrome in Japanese men. Obes Res Clin Pract 2009, 3:65-74.
33. Risch N., Merikangas K. The future of genetic studies of complex human diseases. Science 1996, 273:1516-1517.
34. Smith S., Bai F., Charbonneau C., Janderova L., Argyropoulos G. A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 2003, 52:1611-1618.
35. Pesole G., Mignone F., Gissi C., Grillo G., Licciulli F., Liuni S. Structural and functional features of eukaryotic mRNA untranslated regions. Gene 2001, 276:73-81.
36. Tsukada S., Tanaka Y., Maegawa H., Kashiawagi A., Kawamori R., Maede S. Polymorphisms within TFAP2B regulate transcriptional activity and affect adipocytokine gene expression in differentiated adipocytes. Mol Endocrinol 2006, 20:1104-1111.